Simplex Trading, LLC Synlogic, Inc. Transaction History

Simplex Trading, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$0.58 - $17.99 $143 - $4,461	-248 Reduced 64.08%	139 $0
Q3 2022 Nov 04, 2022	SELL	$0.91 - $14.63 $555 - $8,924	-610 Reduced 61.18%	387 $0
Q2 2022 Aug 03, 2022	BUY	$0.89 - $2.47 $887 - $2,462	997 New	997 $1,000
Q1 2022 May 02, 2022	SELL	$1.63 - $2.55 $7,975 - $12,477	-4,893 Closed	0 $0
Q4 2021 Feb 23, 2022	BUY	$2.27 - $3.0 $11,107 - $14,679	4,893 New	4,893 $11,000
Q2 2021 Aug 12, 2021	SELL	$3.0 - $4.39 $55,878 - $81,768	-18,626 Closed	0 $0
Q1 2021 Apr 26, 2021	BUY	$2.2 - $5.05 $40,977 - $94,061	18,626 New	18,626 $66,000
Q3 2020 Oct 14, 2020	SELL	$1.85 - $2.57 $160 - $223	-87 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$1.59 - $2.51 $9 - $15	-6 Reduced 6.45%	87 $0
Q1 2020 Apr 29, 2020	SELL	$1.39 - $3.19 $2,945 - $6,759	-2,119 Reduced 95.8%	93 $0
Q4 2019 Feb 05, 2020	BUY	$1.96 - $2.81 $2,363 - $3,388	1,206 Added 119.88%	2,212 $5,000
Q3 2019 Oct 15, 2019	BUY	$2.12 - $9.37 $2,132 - $9,426	1,006 New	1,006 $2,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.